Text Size

Dose Response Trial of Pergolide for Cocaine Dependence - 1

This study has been completed.
Sponsor:
Collaborator:
National Institute on Drug Abuse (NIDA)
Information provided by:
Medical University of South Carolina
ClinicalTrials.gov Identifier:
NCT00000248
First received: September 20, 1999
Last updated: September 11, 2012
Last verified: May 1997
History of Changes
  Purpose

The purpose of this study is to evaluate the efficacy and safety of pergolide for treatment of cocaine dependence.


Condition Intervention Phase
Cocaine-Related Disorders
 Drug: Pergolide
 Phase 3

Study Type: Interventional
Study Design: Primary Purpose: Treatment
Official Title: Dose Response Trial of Pergolide for Cocaine Dependence

Resource links provided by NLM:

U.S. FDA Resources

Further study details as provided by Medical University of South Carolina:

Primary Outcome Measures:
  • Side effects
  • Drug use
  • Retention
  • Cocaine withdrawal
  • Compliance
  • Effectiveness of medication for global improvements

Estimated Enrollment: 0
Study Start Date: February 1996
  Eligibility

Ages Eligible for Study:   21 Years to 50 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Please contact site for information.

  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00000248

Locations
United States, South Carolina
Medical University of South Carolina
Charleston, South Carolina, United States, 29425 742
Sponsors and Collaborators
Medical University of South Carolina
National Institute on Drug Abuse (NIDA)
Investigators
Principal Investigator: Robert Malcolm, M.D. Medical University of South Carolina
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00000248     History of Changes
Other Study ID Numbers: NIDA-08355-1, R01DA008355, R01-08355-1
Study First Received: September 20, 1999
Last Updated: September 11, 2012
Health Authority: United States: Federal Government

Additional relevant MeSH terms:
Cocaine-Related Disorders
Substance-Related Disorders
Mental Disorders
Pergolide
Dopamine Agonists
 Dopamine Agents
Neurotransmitter Agents
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Physiological Effects of Drugs

ClinicalTrials.gov processed this record on June 18, 2013